Analytical Data
-
基因名
NAT9
- Application
-
别名
EBSP; Embryo brain specific protein; Embryo brain-specific protein; hNATL; N-acetyltransferase 9; Nacetyltransferase 9; Nat9; NAT9_HUMAN
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9BTE0
-
表达区间
1-207 aa
-
氨基酸序列
MRLNQNTLLL GKKVVLVPYT SEHVPSRYHE WMKSEELQRL TASEPLTLEQ EYAMQCSWQE DADKCTFIVL DAEKWQAQPG ATEESCMVGD VNLFLTDLED LTLGEIEVMI AEPSCRGKGL GTEAVLAMLS YGVTTLGLTK FEAKIGQGNE PSIRMFQKLH FEQVATSSVF QEVTLRLTVS ESEHQWLLEQ TSHVEEKPYR DGSAEPC
-
分子量
23.3 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
NAT9 is a recombinant protein that has garnered attention in the field of molecular biology and biochemistry due to its potential applications in understanding various cellular processes and disease mechanisms. The protein is associated with NAT (N-acetyltransferase) family enzymes, which play crucial roles in the metabolism of various endogenous and exogenous compounds, including drugs and environmental toxins. Research into NAT9 has primarily focused on its enzymatic functions and its implications in pharmacogenomics, particularly in how genetic variations influence drug metabolism and efficacy. Additionally, aberrations in NAT activities have been linked to various diseases, including cancer and neurodegenerative disorders, making NAT9 a target of interest for therapeutic interventions. Studies have utilized recombinant expression systems to produce NAT9, enabling detailed characterization of its biochemical properties and interactions with substrates. Understanding the structure and function of NAT9 could provide insights into its role in human health and disease, paving the way for novel diagnostic and therapeutic approaches.
